ResMed (ASX:RMD) share price drops despite growth in FY22
Jaz Harrison
August 12, 2022
The ResMed Inc (ASX:RMD) share price is currently down 3% despite reporting growth in FY22. It’s expecting more growth in FY23.
Deal done: Why the CSL (ASX:CSL) share price is in focus
Jaz Harrison
August 2, 2022
The CSL Limited (ASX:CSL) share price is making headlines today after ASX healthcare share announced it can finally acquire Vifor.
Is the Volpara Health Technologies Ltd (ASX:VHT) share price a buy?
Owen Raszkiewicz
July 28, 2022
The Volpara Health Technologies (ASX: VHT) share price jumped 6% today after the company released two important updates to the market: its quarterly cash flow report, and findings from CEO Teri Thomas’ strategic review.
Nanosonics (ASX:NAN) share price on watch after FY22 update
Jaz Harrison
July 25, 2022
The Nanosonics Ltd (ASX:NAN) share price is in focus after the ASX healthcare share gave an update about FY22.
Psychology, gambling, investing & writing, a discussion with Graham Witcomb, CFA
Owen Raszkiewicz
July 23, 2022
Graham Witcomb, CFA of The Intelligent Investor joins Owen Rask on The Australian Investors Podcast to talk markets, psychology, life & more.
S&P/ASX 200 (XJO) jumps, Link & EML Payments (EML) in focus
Drew Meredith, CFP
July 12, 2022
The S&P/ASX 200 (INDEXASX: XJO) started Tuesday with a mixed day. The ASX 200 price was up 0.3% with the EML Payments Ltd (ASX:EML) share price and Link (ASX:LNK) share price in focus.
Why the Ramsay (ASX:RHC) share price could shoot higher today
Jaz Harrison
April 20, 2022
The Ramsay Health Care Limited (ASX:RHC) share price could be one of the risers today after receiving a takeover offer.
Why the Fisher & Paykel (ASX:FPH) share price is sinking
Jaz Harrison
March 23, 2022
The Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) share price has sunk more than 5% after giving investors a trading update.
Is it time to buy Cathie Wood’s beaten-up biotech companies (BATS:ARKG)?
Value Downunder
February 25, 2022
Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed biotech stocks have been beaten up mercilessly, so is now the time to buy?
ResMed (ASX:RMD) share price drops despite growth in FY22
August 12, 2022
The ResMed Inc (ASX:RMD) share price is currently down 3% despite reporting growth in FY22. It’s expecting more growth in FY23.
Deal done: Why the CSL (ASX:CSL) share price is in focus
August 2, 2022
The CSL Limited (ASX:CSL) share price is making headlines today after ASX healthcare share announced it can finally acquire Vifor.
Is the Volpara Health Technologies Ltd (ASX:VHT) share price a buy?
July 28, 2022
The Volpara Health Technologies (ASX: VHT) share price jumped 6% today after the company released two important updates to the market: its quarterly cash flow report, and findings from CEO Teri Thomas’ strategic review.
Nanosonics (ASX:NAN) share price on watch after FY22 update
July 25, 2022
The Nanosonics Ltd (ASX:NAN) share price is in focus after the ASX healthcare share gave an update about FY22.
Psychology, gambling, investing & writing, a discussion with Graham Witcomb, CFA
July 23, 2022
Graham Witcomb, CFA of The Intelligent Investor joins Owen Rask on The Australian Investors Podcast to talk markets, psychology, life & more.
S&P/ASX 200 (XJO) jumps, Link & EML Payments (EML) in focus
July 12, 2022
The S&P/ASX 200 (INDEXASX: XJO) started Tuesday with a mixed day. The ASX 200 price was up 0.3% with the EML Payments Ltd (ASX:EML) share price and Link (ASX:LNK) share price in focus.
Why the Ramsay (ASX:RHC) share price could shoot higher today
April 20, 2022
The Ramsay Health Care Limited (ASX:RHC) share price could be one of the risers today after receiving a takeover offer.
Why the Fisher & Paykel (ASX:FPH) share price is sinking
March 23, 2022
The Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) share price has sunk more than 5% after giving investors a trading update.
Is it time to buy Cathie Wood’s beaten-up biotech companies (BATS:ARKG)?
February 25, 2022
Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed biotech stocks have been beaten up mercilessly, so is now the time to buy?
Like our podcast? Get Owen's weekly newsletter.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.